维普中文期刊产品整合服务
41篇 您的检索式:作者名="Soloway M S"
    题名 作者 年代 出处 被引量
1Transitional cell carcinoma of the prostate following intravesical therapy for Transitional cell carcinoma of the bladder 显示文摘Hardeman S W Perry A Soloway M S 1988J Urol1988,140,:1
2Stratification of patients with metastatic cancer based on ex- tent of disease on initial bone scan显示文摘Soloway M S Hardeman S W Hickey D 1988Cancer1988,61,1:1
3Tumor-associated hyaluronic acid:a new sensitive and specific urine marker for bladder cancer显示文摘Lokeshwar V B Obek C Soloway M S 1997Cancer Res1997,57,:1
4Use of a new marker urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment显示文摘Soloway M S Briggman V Carpinito G A 1996J Urol1996,156,2:1
5Contemporary management of stage T1 transitional cell carcinoma of the bladder显示文摘SOLOWAY M S SOFER M VAIDYA A 2002J Urol2002,167,4:1
6Stratifica- tion of patients with metastatic cancer based on extent of disease on initial bonescan 显示文摘Soloway M S Hardeman S W I-Iickey D 1988Cancer1988,61,:1
7Update on bladder neck preservation during radical retropubic prostatectomy: impact on pathologic outcome,anastomotic strictures, and continence 显示文摘SHELFO S W OBEK C SOLOWAY M S 1998Urology1998,51,:1
8Use of a new tumor marker,Urinary NMP22 ,in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment显示文摘Soloway M S Briggman J V Carpinito G A 1996J Urol1996,159,:1
9Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer显示文摘Posey J T Soloway M S Ekici S 2003Cancer Res2003,63,:1
10Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase(HYAL1) for prostate cancer显示文摘Poscy J T Soloway M S Ekici S 2003Cancer Res2003,63,10:1
11Optimal management of the T1G3 bladder cancer 显示文摘Manoharan M Soloway M S 2005Urol Clin North Am2005,32,2:1
12Optimal management of the T1G3 bladder cancer显示文摘MANOHARAN M SOLOWAY M S 2005Urol Clin North Am2005,32,:1
13Editorial comment on zEAU guidelines on non-mus- cle-invasive urothelial carcinoma of the bladder 显示文摘Soloway M S 2008Eur Urol2008,54,2:1
14Antiandrogenic agents as monotherapy in advanced prostatic carcinoma显示文摘Soloway M S Matzkin H 1993Cancer1993,71,3:1
15Bladdeneck preservation during radical retropubic prostatectomy显示文摘Soloway M S Neulander E 2000Semin Urol ()neol2000,18,:1
16Update on bladder neck preservation during radical retropubic prostatectomy: impact on pathological outcome, anastomotic strictures,and continence显示文摘 Obek C Soloway M S 1998Urology1998,51,1:1
17Stratification of patients with metastatic cancer based on extent of disease on initial bone scan显示文摘Soloway M S Hardeman S W Hickey D 1988Cancer1988,61,:1
18Bladder neck preservation and its impact on positive surgical margins during radical prostatectomy显示文摘Gomez C A Soloway M S Civantos F 1993Urology1993,42,6:1
19Optimal management of the T1G3 bladder cancer显示文摘Manoharan M Soloway M S 2005Urol Clin North Am2005,32,:1
20Transiti- onal cell carcinoma of the prostate 显示文摘MATZKIN H SOLOWAY M S HARDEMAN S 1991J Urol1991,146,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费